ETRA · ISSUER CIK 2088082
Electra Therapeutics, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 6 Electra Therapeutics, Inc. insiders reported $40.0M of open-market purchases and $0.00 of sales on SEC Form 4. The largest buyer was Gordon Carl L (Director, 10% Owner), with $20.0M.
↗6 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$40.0MInsider buying
$0.00Insider selling
+$40.0MNet open-market
Sep 23, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 23, 202617:35 | Sep 21, 2026 | ETRA | Director, 10% Owner | P · Buy | $15.00 | +1,333,333 | 1,758,279 | +314% | +$20.0M | +13.2% | -42.4% |
| Sep 23, 202617:35 | Sep 21, 2026 | ETRA | Director, 10% Owner | C · Convert | — | +5,551,837 | 758,279 | — | — | ||
| Sep 23, 202617:29 | Sep 21, 2026 | ETRA | Director, 10% Owner · +2 joint | P · Buy | $15.00 | +1,333,333 | 1,758,279 | +314% | +$20.0M | +13.2% | -42.4% |
| Sep 23, 202617:29 | Sep 21, 2026 | ETRA | Director, 10% Owner · +2 joint | C · Convert | — | +5,551,837 | 758,279 | — | — | ||
| Sep 21, 202618:20 | Sep 21, 2026 | ETRA | Chief Technical Officer | C · Convert | — | +63,656 | 63,656 | New | — | ||
| Sep 21, 202618:19 | Sep 21, 2026 | ETRA | Director | C · Convert | — | +255,635 | 255,635 | New | — | ||
| Sep 21, 202618:17 | Sep 21, 2026 | ETRA | Chief Scientific Officer | C · Convert | — | +85,504 | 85,504 | New | — | ||
| Sep 21, 202618:14 | Sep 21, 2026 | ETRA | President & CEO, Director | C · Convert | — | +455,484 | 455,484 | New | — |